GENE ONLINE|News &
Opinion
Blog

Antibody-Drug Conjugate
Sparx Therapeutics to Build a Massive Manufacturing Plant in China for Multi-Specific Antibody Production
2021-07-10
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
As BIO 2021 Approaches, Taiwan’s DCB Reveals Competitive Bio-Innovations to Watch Out For
2021-06-11
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
New Frontiers in Therapeutics
2020-07-25Partner
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
ASCO 2020: AstraZeneca and Daiichi Sankyo’s Enhertu Impresses with Benefits in Lung, Stomach and Colorectal Cancer Trials
2020-06-05
Enhertu, AstraZeneca’s Drug against Gastric Cancer Gets Breakthrough Therapy Designation
2020-05-14
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
1 2
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top